Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.
- NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_assertion wasGeneratedBy ECO_0000203 NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.
- NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_assertion wasDerivedFrom befree-20140225 NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.
- NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_assertion SIO_000772 23658459 NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.
- NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_assertion evidence source_evidence_literature NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.
- NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_assertion description "[When qPCR-identified amplifications in FGFR1, FGFR2, or FGF3 were grouped to define an FGF pathway-amplified breast cancer in HR-positive patients, the mean reduction in target lesions was 21.1% compared with a 12.0% increase in patients who did not present with FGF pathway-amplified breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.
- befree-20140225 importedOn "2014-02-25" NP776076.RAM4F6qxCBPzqUdOyGb2Chjuwnsv4gdwqYDvv-r3dNf9U130_provenance.